In order to further promote the continuous development of cancer diagnosis and treatment in the Sichuan and Hubei regions, improve the quality of clinical treatment, and strengthen academic exchanges in the Sichuan and Hubei regions, the Chengdu High-tech Medical Association held an online training course on new developments in cancer diagnosis and treatment on October 13, 2021.

The meeting invited Professor Liu Xianling from the Second Xiangya Hospital of Central South University to give an opening speech and summary, and gave an explanation of "Using PAPID software to accurately guide AIS emergency intravascular interventional treatment"; Professor Ding Wanjun from the People's Hospital of Wuhan University shared the " 2021 ASCO NSCLC Targeting and New Advances in Anti-vascular Therapy; Professor Zhao Jing from Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology focused on "Exploration and Optimization of Recombinant Human Endostatin Dose". The participating experts and professors conducted topical questions, opinions sharing and discussions based on the reports of experts and scholars.

This conference provides a platform for clinical medical practitioners and scientific researchers to exchange diagnosis and treatment technology and academic research results, which is conducive to the promotion of clinical scientific research and the academic development of medical oncology, as well as the promotion of high-quality clinical research in the field of medical oncology. It is of great significance to promote the level of clinical scientific research.